Identifying proteomic profiles and biological networks of early state ovarian cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2110320
Recipient
Awarding agency
Obligated
$1,297,718

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02115, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded Brigham & Women's Hospital Inc. a $1,297,718 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the identification of proteomic profiles and biological networks of early stage ovarian cancer from May 1, 2021 to April 30, 2025. Through this research, the grantee aims to transform healthcare for service members and the public by investigating medical solutions for the battlefield and developing innovative approaches to diagnose and treat ovarian cancer. The total funding amount of $1,297,718 will support the grantee's work analyzing protein expression patterns and interactions associated with early ovarian cancer toward developing new diagnostic and treatment strategies over the four year grant period.

Quick answers

Who received award W81XWH2110320?

W81XWH2110320 was awarded to Brigham & Womens Hospital Inc. by Medical Command (Department of the Army) on May 1, 2021.

How much is award W81XWH2110320 worth?

$1,297,718 has been obligated on W81XWH2110320.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login